COHR

Coherent, Inc.

70
Fundamentals72/ 100
Valuation44/ 100
Upside potential88/ 100
Risk potential19/ 100

COHR's outlook is improving, though it still trails on the overall score.

SKHY

SK hynix Inc.

79
Fundamentals95/ 100
Valuation50/ 100
Upside potentialUnknown
Risk potentialUnknown

SKHY has the edge over COHR overall, supported by stronger fundamentals and stronger valuation.

COHR Fundamentals

MetricStatus
Strong
Strong
Weak
Healthy

COHR's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.

SKHY Fundamentals

MetricStatus
Strong
Strong
Strong
Strong

SKHY's revenue, profitability, cash flow and balance sheet are all currently strong.

COHR PE Valuation

CHEAPFAIREXPENSIVE87x174x261x348x
CHEAPFAIREXPENSIVE87x174x261x348x
LevelPEPriceVs current
Forward20x$232—
Cheap27x$130-44%
Fair34x$165-29%
Current48x$232—
Expensive184x$886+282%

Historical ranges are pointers, not guarantees.

COHR's PE is in its fair range at 48x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its cheap range.

SKHY PE Valuation

SKHY has no meaningful PE right now: it lost money over the past year.

COHR Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Moderate
Moderate

Analysts expect strong earnings and revenue growth for COHR, with profitability improving.

SKHY Forward outlook

MetricOutlook
--
Strong growth
Strong growth
Strongly improving
Limited
Low

Analysts expect strong earnings and revenue growth for SKHY, with profitability improving. However, they disagree widely on these estimates.

COHR Risk to reward

ScenarioChangePrice
Upside+138%$551.66
Downside-19%$187.45

Calculated from the latest close: $232.08 on Nov 12.

There is not enough scenario data to compare COHR and SKHY's risk to reward.

SKHY Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $137.71 on Nov 12.

There is not enough scenario data to compare COHR and SKHY's risk to reward.

COHR Earnings Per Share

Q4 2023: $-2.82Q1 2024: $-2.87Q2 2024: $-1.84Q3 2024: $-1.23Q4 2024: $-0.41Q1 2025: $-0.23Q2 2025: $-0.52Q3 2025: $0.71Q4 2025: $1.03Q1 2026: $2.11Q2 2026: $4.12Q3 2026: $4.83Forward: $11.69
Q4 2023: $-2.82Q1 2024: $-2.87Q2 2024: $-1.84Q3 2024: $-1.23Q4 2024: $-0.41Q1 2025: $-0.23Q2 2025: $-0.52Q3 2025: $0.71Q4 2025: $1.03Q1 2026: $2.11Q2 2026: $4.12Q3 2026: $4.83Forward: $11.69
QuarterTTM EPSYoY
Forward$11.69+142%
Q3 2026$4.83+580%
Q2 2026$4.12+$4.64
Q1 2026$2.11+$2.34
Q4 2025$1.03+$1.44
Q3 2025$0.71+$1.94
Q2 2025-$0.52+$1.32
Q1 2025-$0.23+$2.64
Q4 2024-$0.41+$2.41

COHR's earnings per share have climbed steadily: $4.83 over the past year, about seven times what it earned the year before, and higher year over year for 10 quarters in a row.

SKHY Earnings Per Share

Q3 2023: $-1.25Q4 2023: $-0.99Q1 2024: $-0.50Q2 2024: $0.27Q3 2024: $1.10Q4 2024: $2.12Q1 2025: $2.76Q2 2025: $3.04Q3 2025: $3.78Q4 2025: $4.52Q1 2026: $7.91Q2 2026: $17.04
Q3 2023: $-1.25Q4 2023: $-0.99Q1 2024: $-0.50Q2 2024: $0.27Q3 2024: $1.10Q4 2024: $2.12Q1 2025: $2.76Q2 2025: $3.04Q3 2025: $3.78Q4 2025: $4.52Q1 2026: $7.91Q2 2026: $17.04
QuarterTTM EPSYoY
Q2 2026$17.04+461%
Q1 2026$7.91+187%
Q4 2025$4.52+113%
Q3 2025$3.78+244%
Q2 2025$3.04+1026%
Q1 2025$2.76+$3.26
Q4 2024$2.12+$3.11
Q3 2024$1.10+$2.35

SKHY's earnings per share have climbed steadily: $17.04 over the past year, about six times what it earned the year before, and higher year over year for nine quarters in a row.

COHR Quarterly Revenue

Q4 2023: $1.1BQ1 2024: $1.2BQ2 2024: $1.3BQ3 2024: $1.3BQ4 2024: $1.4BQ1 2025: $1.5BQ2 2025: $1.5BQ3 2025: $1.6BQ4 2025: $1.7BQ1 2026: $1.8BQ2 2026: $2BQ3 2026: $2.4B
Q4 2023: $1.1BQ1 2024: $1.2BQ2 2024: $1.3BQ3 2024: $1.3BQ4 2024: $1.4BQ1 2025: $1.5BQ2 2025: $1.5BQ3 2025: $1.6BQ4 2025: $1.7BQ1 2026: $1.8BQ2 2026: $2BQ3 2026: $2.4B
QuarterRevenueYoY
Q3 2026$2.4B+50%
Q2 2026$2B+34%
Q1 2026$1.8B+21%
Q4 2025$1.7B+17%
Q3 2025$1.6B+17%
Q2 2025$1.5B+16%
Q1 2025$1.5B+24%
Q4 2024$1.4B+27%

COHR's revenue has grown year over year for 10 quarters in a row: $2.4B last quarter, up 50% from the same quarter a year ago.

SKHY Quarterly Revenue

Q3 2023: $6.8BQ4 2023: $8.5BQ1 2024: $9.3BQ2 2024: $12.3BQ3 2024: $13.2BQ4 2024: $14.8BQ1 2025: $13.2BQ2 2025: $16.7BQ3 2025: $18.3BQ4 2025: $24.6BQ1 2026: $39.4BQ2 2026: $59.4B
Q3 2023: $6.8BQ4 2023: $8.5BQ1 2024: $9.3BQ2 2024: $12.3BQ3 2024: $13.2BQ4 2024: $14.8BQ1 2025: $13.2BQ2 2025: $16.7BQ3 2025: $18.3BQ4 2025: $24.6BQ1 2026: $39.4BQ2 2026: $59.4B
QuarterRevenueYoY
Q2 2026$59.4B+257%
Q1 2026$39.4B+198%
Q4 2025$24.6B+66%
Q3 2025$18.3B+39%
Q2 2025$16.7B+35%
Q1 2025$13.2B+42%
Q4 2024$14.8B+75%
Q3 2024$13.2B+94%

SKHY has the edge over COHR on sales, with stronger typical year-over-year growth.

COHR Free Cash Flow

Q4 2023: −$24MQ1 2024: $24MQ2 2024: $62MQ3 2024: $61MQ4 2024: $82MQ1 2025: $51MQ2 2025: −$1MQ3 2025: −$58MQ4 2025: −$96MQ1 2026: −$383MQ2 2026: −$486MQ3 2026: −$868M
Q4 2023: −$24MQ1 2024: $24MQ2 2024: $62MQ3 2024: $61MQ4 2024: $82MQ1 2025: $51MQ2 2025: −$1MQ3 2025: −$58MQ4 2025: −$96MQ1 2026: −$383MQ2 2026: −$486MQ3 2026: −$868M
QuarterFree cash flowYoY
Q3 2026-$868.2M-$810.2M
Q2 2026-$486.2M-$485.2M
Q1 2026-$383.5M-850%
Q4 2025-$95.7M-217%
Q3 2025-$58M-195%
Q2 2025-$1.1M-102%
Q1 2025$51.1M+111%
Q4 2024$81.7M+$106M

COHR's free cash flow has turned negative after years in the green: −$1.8B over the past year.

SKHY Free Cash Flow

Q3 2023: −$438MQ4 2023: $1.6BQ1 2024: $1.6BQ2 2024: $2.7BQ3 2024: $3BQ4 2024: $2.7BQ1 2025: $1.9BQ2 2025: $3.4BQ3 2025: $6.8BQ4 2025: $6.5BQ1 2026: $13.8BQ2 2026: $41.2B
Q3 2023: −$438MQ4 2023: $1.6BQ1 2024: $1.6BQ2 2024: $2.7BQ3 2024: $3BQ4 2024: $2.7BQ1 2025: $1.9BQ2 2025: $3.4BQ3 2025: $6.8BQ4 2025: $6.5BQ1 2026: $13.8BQ2 2026: $41.2B
QuarterFree cash flowYoY
Q2 2026$41.2B+1111%
Q1 2026$13.8B+619%
Q4 2025$6.5B+142%
Q3 2025$6.8B+127%
Q2 2025$3.4B+26%
Q1 2025$1.9B+20%
Q4 2024$2.7B+67%
Q3 2024$3B+$3.4B

SKHY has the edge over COHR on cash generation, producing positive trailing cash flow while its opponent burns cash.

COHR Total Shares

Q4 2023: 152MQ1 2024: 152MQ2 2024: 152MQ3 2024: 154MQ4 2024: 160MQ1 2025: 155MQ2 2025: 155MQ3 2025: 191MQ4 2025: 193MQ1 2026: 196MQ2 2026: 195MQ3 2026: 202M
Q4 2023: 152MQ1 2024: 152MQ2 2024: 152MQ3 2024: 154MQ4 2024: 160MQ1 2025: 155MQ2 2025: 155MQ3 2025: 191MQ4 2025: 193MQ1 2026: 196MQ2 2026: 195MQ3 2026: 202M
PeriodChange %Net change
Quarterly+3.4%+6.6M shares
1 year+5.9%+11.3M shares
3 years+34%+51.7M shares
5 years+74%+86.2M shares
Available history+122%+111M shares

COHR has 202M diluted shares, up 5.9% from a year ago.

SKHY Total Shares

Q3 2023: 6.9BQ4 2023: 6.9BQ1 2024: 6.9BQ2 2024: 7.1BQ3 2024: 7.1BQ4 2024: 6.9BQ1 2025: 6.9BQ2 2025: 7.1BQ3 2025: 7.1BQ4 2025: 7.1BQ1 2026: 7.1BQ2 2026: 7.1B
Q3 2023: 6.9BQ4 2023: 6.9BQ1 2024: 6.9BQ2 2024: 7.1BQ3 2024: 7.1BQ4 2024: 6.9BQ1 2025: 6.9BQ2 2025: 7.1BQ3 2025: 7.1BQ4 2025: 7.1BQ1 2026: 7.1BQ2 2026: 7.1B
PeriodChange %Net change
Quarterly+0.2%+14.8M shares
1 year+0.2%+14.8M shares
3 years+3.7%+254M shares
5 years+3.9%+268M shares
Available history+4.3%+294M shares

SKHY has the edge over COHR on shareholder dilution, with a more favorable share count trend.

COHR Net Leverage

Q4 2023: 6.0xQ1 2024: 6.6xQ2 2024: 4.8xQ3 2024: 4.8xQ4 2024: 4.6xQ1 2025: 5.1xQ2 2025: 8.1xQ3 2025: 4.1xQ4 2025: 3.5xQ1 2026: 1.7xQ2 2026: 1.5xQ3 2026: 1.7x
Q4 2023: 6.0xQ1 2024: 6.6xQ2 2024: 4.8xQ3 2024: 4.8xQ4 2024: 4.6xQ1 2025: 5.1xQ2 2025: 8.1xQ3 2025: 4.1xQ4 2025: 3.5xQ1 2026: 1.7xQ2 2026: 1.5xQ3 2026: 1.7x
QuarterNet LeverageStatus
Q3 20261.7xHealthy
Q2 20261.5xHealthy
Q1 20261.7xHealthy
Q4 20253.5xElevated
Q3 20254.1xHigh
Q2 20258.1xHigh
Q1 20255.1xHigh
Q4 20244.6xHigh

COHR's net debt is about 1.7 years of its operating earnings (EBITDA), down from 4.1 years a year ago.

SKHY Net Leverage

Q3 2023: 23.3xQ4 2023: 7.2xQ1 2024: 2.7xQ2 2024: 1.2xQ3 2024: 0.6xQ4 2024: 0.4xQ1 2025: 0.3xQ2 2025: 0.3xQ3 2025: 0.3xQ4 2025: 0.2xQ1 2026: 0.0xQ2 2026: -0.0x
Q3 2023: 23.3xQ4 2023: 7.2xQ1 2024: 2.7xQ2 2024: 1.2xQ3 2024: 0.6xQ4 2024: 0.4xQ1 2025: 0.3xQ2 2025: 0.3xQ3 2025: 0.3xQ4 2025: 0.2xQ1 2026: 0.0xQ2 2026: -0.0x
QuarterNet LeverageStatus
Q2 2026-0.0xNet Cash
Q1 20260.0xVery low
Q4 20250.2xVery low
Q3 20250.3xVery low
Q2 20250.3xVery low
Q1 20250.3xVery low
Q4 20240.4xVery low
Q3 20240.6xVery low

SKHY has the edge over COHR on leverage, with a lower net debt burden relative to earnings.

COHR Weekly Momentum

MetricValueStatus
RSI43.6Neutral
Stochastic16.5Oversold

COHR's weekly RSI is 44 (neutral) and its Stochastic is 16 (oversold).

SKHY Weekly Momentum

MetricValueStatus
RSI28.7Oversold
Stochastic19.7Oversold

SKHY's weekly RSI is 29 (oversold) and its Stochastic is 20 (oversold).

COHR PE vs Technology Sector

MetricCOHRSector medianRelative
PE48x28x72% above
PE %583523 pts above

COHR is trading at 48x earnings, a 72% premium to the Technology sector's median of 28x.

SKHY PE vs Technology Sector

SKHY has no meaningful PE right now: it lost money over the past year.

COHR Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$252.98.2% below
20 week MA$284.118% below
50 week MA$277.716% below
100 week MA$185.925% above
200 week MA$120.692% above

COHR has stronger trend alignment. COHR is above 2 of 5 weekly averages versus SKHY above 0 of 1.

SKHY Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$155.411% below

SKHY is in a downtrend: it's below all one of its weekly moving averages, and 11% below its 8-week average.

COHR Yearly ROI

YearStart priceEnd priceROI
2020$33.5$77.8+132%
2021$77.8$68.0-13%
2022$68.0$33.1-51%
2023$33.1$43.5+32%
2024$43.5$97.0+123%
2025$97.0$191.7+98%
2026 YTD$191.7$232.1+21%

COHR has the edge over SKHY on returns for 2026, with the stronger performance.

SKHY Yearly ROI

YearStart priceEnd priceROI
2026 YTD$168.0$137.7-18%

It's down 18% so far in 2026.

Give your agent the market.

Get API key